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VAbstract
Ultraviolet radiation (UVR) causes mutagenic DNA damage to skin cells and
suppression of the skin immune system (SIS) that contributes to skin cancer
development. UVR in the UVB range also causes the beneficial production of vitamin
D3 by keratinocytes. Keratinocytes also contain the enzymes required for the two-step
hydroxylation of vitamin D3 is to its biologically active form: 1α,25 dihydroxyvitamin
D3 (1α,25 (OH)2D3). 1α,25 (OH)2D3 has been demonstrated to modulate the SIS and
its response to UVB irradiation. Topical application of 1α,25 (OH)2D3 suppresses the
SIS and protects against UV-induced DNA damage. This thesis investigates the
hypothesis that dietary vitamin D3 similarly suppresses the SIS response via modulation
of the SIS and protects against UVB induced immunosuppression via a reduction in
UVB induced DNA damage.
To assess the influence of vitamin D3 on the development and function of the SIS, and
the skins response to UVR, a vitamin D3 deficient mouse population was developed.
Breeding pairs of vitamin D3 replete and vitamin D3 deficient mice were formed and
the off-spring of these mice were used in experiments. The contact hypersensitivity
(CHS) response was used to assess the SIS function in vitamin D3 replete and vitamin
D3 deficient mice. In this model the application of the contact sensitiser to the skin of
neonatal mice leads to suppression of the CHS response upon subsequent re-
sensitisation and elicitation of the CHS in adulthood. The suppression of the CHS
response is termed ‘neonatal tolerance’.
Vitamin D3 enhanced neonatal tolerance in male but not female mice. The enhanced
neonatal tolerance induction related to an increase in the proportion of CD4+CD25+
cells in vitamin D3 replete neonatal male mice and this cell population could transfer
tolerance in this mouse group. Vitamin D3 suppressed the CHS response in adult male
but not adult female mice. An investigation of DC function in adult mice revealed no
modulation by vitamin D3 in antigen carriage or co-stimulatory molecule expression,
suggesting that these cells were not modulating the reduced CHS response in adult male
mice. However, dietary vitamin D3 was associated with a higher proportion of
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CD4+CD25+ cells in the SDLN after contact sensitiser application in male but not
female mice, implying that vitamin D3 was modulating the induction of these cells.
The level of UVB-induced immunosuppression was assessed in vitamin D3 replete and
deficient mice in C57BL/6 and BALB/c mice. Vitamin D3 protected C57BL/6, but not
BALB/c mice against UVB-induced immunosuppression. The protection against UVB-
induced immunosuppression may relate to a reduction in UVB-induced DNA damage in
C57BL/6 mice, not identified in BALB/c mice. In BALB/c mice female gender
protected against UVB-induced immunosuppression and was associated with a subtle
lowering of UVB-induced DNA damage in comparison to male mice at low UVR
exposures. These results indicate that the protection against UVB-induced
immunosuppression by vitamin D3 varies with genetic background and the modulation
of UVB-induced DNA damage.
If these mouse studies are extended to humans, the ability of vitamin D3 to suppress the
SIS and the limited protection against UVB-induced DNA damage in males, depending
on their genetic background, may contribute to the greater burden of skin cancer in
males than in females.
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Commonly Used Abbreviations
APC Antigen Presenting Cells
BCC Basal Cell Carcinoma
CHS Contact Hypersensitivity
ConA  Concanavalin A
CCR Chemokine Receptor
CCL Chemokine Ligand
cDC conventional or classical Dendritic Cell
CTLA-4 Cytotoxic T-lymphocyte Antigen 4
CLA Cutaneous Lymphocyte Antigen
CPD Cyclobutane Pyrimidine Dimer
DC Dendritic Cells
7-DHC 7- dehydrocholesterol
EAE Experimental Autoimmune Encephalomyelitis
FITC Fluoroscein Isothiocyanate
Flt3 fms-related tyrosine kinase 3
IBD Inflammatory Bowel Disease
IFN Interferon
IL Interleukin
iNKT invariant Natural Killer T cell
iTreg induced regulatory T cell
LC Langerhans cell
MCP-1 Monocyte Chemoattractant Protein- 1
MHC Major Histocompatibility Complex
MMP Matrix Metalloproteinase
MS Multiple Sclerosis
MT Metallothionein
NK Natural Killer
NMSC Non-Melanoma Skin Cancer
NOD Non-obese Diabetic
nTregs: naturally occurring regulatory T cells
IX
PAF Platelet Activating Factor
pDC plasmacytoid Dendritic Cell
PGE2 Prostaglandin E2
RANK Receptor Activator for Nuclear Factor κ B
RANKL Receptor Activator for Nuclear Factor κ B Ligand
ROS Reactive Oxygen Species
SDLN Skin Draining Lymph Nodes
SEM Standard Error of the Mean
SD Standard Deviation
SCC Squamous Cell Carcinoma
SIS Skin Immune System
TD Thymine Dimers
TCR T Cell Receptor
Th T helper
TGF-β Transforming Growth Factor β
Treg Regulatory T cell
UCA Urocanic Acid
UV Ultraviolet
UVR Ultraviolet Radiation
VDR Vitamin D Receptor
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30 Foreword
Skin cancer is the most common cancer in the world. The majority of skin cancers are
caused by exposure of the skin to ultraviolet B radiation (UVB). UVB irradiation causes
DNA damage to cells of the skin and suppression of the skin immune system (SIS).
UVB irradiation also causes the production of vitamin D3 by skin keratinocytes.
Vitamin D3 is enzymatically hydroxylated to produce 25(OH)D3, which is the major
circulating form of vitamin D3. 25(OH)D3 is then available for a further hydroxylation
to become it’s biologically active form 1α,25 dihydroxyvitamin D3 (1α,25(OH)2D3) by
a variety of cells including cells of the skin and the SIS. Keratinocytes of the skin
produce 1α,25(OH)2D3 after UVB irradiation and this has led to the discovery that
1α,25(OH)2D3 can suppress the function of key cells of the SIS and protects skin
against UVB-induced DNA damage and UVB-induced immunosuppression. This may
contribute to a reduced risk of skin cancer development. The focus of this study was to
determine whether dietary vitamin D3, and therefore circulating levels of 25(OH)D3
available to be converted to 1α,25(OH)2D3, similarly influenced the development and
function of the SIS and the skins response to UVB-irradiation.
A vitamin D3 deficient mouse population was developed to elucidate the role of dietary
vitamin D3 on the development and function of the SIS and response to UVB-
irradiation. An immune response known as the contact hypersensitivity (CHS) response,
generated by the SIS upon skin exposure to an antigen (contact sensitiser) was
compared in vitamin D3 replete and vitamin D3 deficient mice. The investigation of the
development and function of the SIS involved an assessment of the directors of the CHS
response, dendritic cells (DC); the effectors of the CHS response, T and B cells; and
regulators of the CHS, regulatory T cells. UVB-induced suppression of the SIS was also
investigated to ascertain the role of dietary vitamin D3 on the skins response to UVB-
irradiation. Vitamin D3 subtly altered DC, CHS effectors and regulatory T cells in an
age and gender specific manner. Similarly vitamin D3 protected against UVB-induced
immunosuppression in a gender and mouse strain dependent manner. As vitamin D3
deficiency and skin cancer are common, it is important to clarify how vitamin D3
modulates cutaneous biology and how this may relate to skin cancer development.
